BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Calisti G, Muhindo R, Boum Y 2nd, Wilson LA, Foster GM, Geretti AM, Bhagani S. Epidemiology of HBV infection in a cohort of Ugandan HIV-infected patients and rate and pattern of lamivudine-resistant HBV infection in patients receiving antiretroviral therapy. Trans R Soc Trop Med Hyg 2015;109:723-9. [PMID: 26386408 DOI: 10.1093/trstmh/trv077] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
Number Citing Articles
1 Price H, Dunn D, Zachary T, Vudriko T, Chirara M, Kityo C, Munderi P, Spyer M, Hakim J, Gilks C, Kaleebu P, Pillay D, Gilson R; DART Virology Group. Hepatitis B serological markers and plasma DNA concentrations. AIDS 2017;31:1109-17. [PMID: 28328795 DOI: 10.1097/QAD.0000000000001454] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
2 Seremba E, Ocama P, Ssekitoleko R, Mayanja-Kizza H, Adams SV, Orem J, Katabira E, Reynolds SJ, Nabatanzi R, Casper C, Phipps W. Immune response to the hepatitis B vaccine among HIV-infected adults in Uganda. Vaccine 2021;39:1265-71. [PMID: 33516601 DOI: 10.1016/j.vaccine.2021.01.043] [Reference Citation Analysis]
3 Singh KP, Crane M, Audsley J, Avihingsanon A, Sasadeusz J, Lewin SR. HIV-hepatitis B virus coinfection: epidemiology, pathogenesis, and treatment. AIDS. 2017;31:2035-2052. [PMID: 28692539 DOI: 10.1097/qad.0000000000001574] [Cited by in Crossref: 96] [Cited by in F6Publishing: 49] [Article Influence: 24.0] [Reference Citation Analysis]
4 Chambal LM, Gudo ES, Carimo A, Corte Real R, Mabunda N, Maueia C, Vubil A, Zicai AF, Bhatt N, Antunes F. HBV infection in untreated HIV-infected adults in Maputo, Mozambique. PLoS One 2017;12:e0181836. [PMID: 28759595 DOI: 10.1371/journal.pone.0181836] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
5 Ambachew H, Zheng M, Pappoe F, Shen J, Xu Y. Genotyping and sero-virological characterization of hepatitis B virus (HBV) in blood donors, Southern Ethiopia. PLoS One 2018;13:e0193177. [PMID: 29462187 DOI: 10.1371/journal.pone.0193177] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
6 de Mendoza C, Bautista JM, Pérez-Benavente S, Kwawu R, Fobil J, Soriano V, Díez A. Screening for retroviruses and hepatitis viruses using dried blood spots reveals a high prevalence of occult hepatitis B in Ghana. Ther Adv Infect Dis 2019;6:2049936119851464. [PMID: 31205689 DOI: 10.1177/2049936119851464] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
7 Mokaya J, McNaughton AL, Hadley MJ, Beloukas A, Geretti AM, Goedhals D, Matthews PC. A systematic review of hepatitis B virus (HBV) drug and vaccine escape mutations in Africa: A call for urgent action. PLoS Negl Trop Dis 2018;12:e0006629. [PMID: 30080852 DOI: 10.1371/journal.pntd.0006629] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 8.8] [Reference Citation Analysis]